4 Biotech Movers Bring New Hope to Huntington’s, Cancer Patients
Clinical updates from uniQure, NTHI, and others signal tangible progress in gene therapy and oncology, offering potential new treatment options for patients with devastating diseases.
Healthcare entity
NEO212
ProductAll 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AMT-130, the most common co-covered peer. NEO212 appears in 1 tracked Healthcare story from June 19, 2026. The tracked stories average 2 original sources each.
Last mentioned: Jun 19, 2026
Entity pulse
Recent coverage · NEO212
1 story
avg impact
100% positive
0% negative
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
What the coverage shows about NEO212
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AMT-130, the most common co-covered peer. NEO212 appears in 1 tracked Healthcare story from June 19, 2026. The tracked stories average 2 original sources each.
- Stories tracked
- 1
- Sources per story
- 2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering NEO212. Shared-story counts are live from our verified record — not editorial picks.
Stories mentioning NEO212 1
NEO212 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.